Nanozora (ozoralizumab) / Taisho, Sanofi, EddingPharm 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nanozora (ozoralizumab) / Sanofi, Taisho
NCT04077567: An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis

Completed
3
401
Japan
TS-152, ozoralizumab
Taisho Pharmaceutical Co., Ltd.
Rheumatoid Arthritis
04/23
04/23

Download Options